Literature DB >> 1505290

Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects.

M B Grisham1, K Ware, S Marshall, T Yamada, I S Sandhu.   

Abstract

There is a growing body of experimental and clinical evidence to suggest that oral or rectal administration of 5-ASA or 5-ASA conjugates is associated with significant adverse side effects including pancreatitis, hepatitis, and renal toxicity. The objective of this study was to assess the ability of 5-ASA to interact with low-molecular-weight iron to yield oxygen-derived free radicals and to determine whether these oxidants could damage model biological compounds. We found that 5-ASA was very effective at chelating ferric iron (Fe3+), and it rapidly reduced Fe3+ to the ferrous form (Fe2+). Addition of the 5-ASA/Fe2+ chelate to solutions containing polyunsaturated fatty acids or deoxyribose resulted in lipid peroxidation and oxidative carbohydrate degradation, respectively. These results are consistent with the formation of the highly reactive (and cytotoxic) hydroxyl radical. Formation of this free radical species was confirmed by the ability of hydroxyl radical scavengers (dimethyl sulfoxide, dimethyl thiourea) to inhibit the 5-ASA/Fe-mediated oxidative reactions. Maximum hydroxyl radical formation was achieved at a 5-ASA-to-Fe3+ ratio of 1.0 (20 microM 5-ASA and 20 microM Fe3+). Increasing this ratio significantly inhibited OH. formation with a concomitant reduction in lipid peroxidation and deoxyribose degradation. Finally, we demonstrated that 5-ASA promotes the reductive release of Fe3+ from ferritin. Data obtained in this study suggest that 5-ASA may, under certain conditions, promote the formation of potentially injurious free radical species. These oxidative reactions may contribute to some of the adverse side effects known to be associated with the newer preparations of 5-ASA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505290     DOI: 10.1007/bf01296008

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Acute pancreatitis during oral 5-aminosalicylic acid therapy.

Authors:  M T Fiorentini; M Fracchia; G Galatola; A Barlotta; M de la Pierre
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

2.  Effect of 5-aminosalicylic acid on ferrous sulfate-mediated damage to deoxyribose.

Authors:  M B Grisham
Journal:  Biochem Pharmacol       Date:  1990-06-15       Impact factor: 5.858

Review 3.  Role of free radicals and catalytic metal ions in human disease: an overview.

Authors:  B Halliwell; J M Gutteridge
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload.

Authors:  B R Bacon; C H Park; G M Brittenham; R O'Neill; A S Tavill
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

5.  5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage.

Authors:  B J Dull; K Salata; A Van Langenhove; P Goldman
Journal:  Biochem Pharmacol       Date:  1987-08-01       Impact factor: 5.858

6.  Inhibition of antibody secretion by 5-aminosalicylic acid.

Authors:  R P MacDermott; S R Schloemann; M J Bertovich; G S Nash; M Peters; W F Stenson
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

7.  Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases.

Authors:  P Biemond; H G van Eijk; A J Swaak; J F Koster
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 8.  Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites.

Authors:  M B Grisham; D N Granger
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

9.  Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.

Authors:  P A van Hees; J H Bakker; J H van Tongeren
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

10.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

View more
  5 in total

1.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

Review 2.  Oxygen radicals, nitric oxide and human inflammatory joint disease.

Authors:  B Halliwell
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

3.  Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis.

Authors:  G Frieri; R Giacomelli; M Pimpo; G Palumbo; A Passacantando; G Pantaleoni; R Caprilli
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

4.  Prevention of acetic acid-induced colitis by desferrithiocin analogs in a rat model.

Authors:  Raymond J Bergeron; Jan Wiegand; William R Weimar; John Nhut Nguyen; Charles A Sninsky
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

5.  Optical Detection of Fe3+ Ions in Aqueous Solution with High Selectivity and Sensitivity by Using Sulfasalazine Functionalized Microgels.

Authors:  Weiming Ji; Zumei Zhu; Shunni Dong; Jingjing Nie; Binyang Du
Journal:  Sensors (Basel)       Date:  2019-09-28       Impact factor: 3.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.